Botulinum neurotoxin type‐A (BoNT‐A) has been used in association with other
interventions in the management of spasticity in children with cerebral palsy (CP) for almost …

Background The aim of this pilot study was to examine the effects of additional resistance
training after use of Botulinum Toxin-A (BoNT-A) on the upper limbs in children with cerebral …

This study compared clinical and functional outcomes after treatment with botulinum toxin A
(BTX-A) and BTX-A with casting in children with dynamic equinus foot. Ten children (seven …

Background/Aim. Cerebral palsy (CP) is the most common physical disability in childhood.
Children have problems with motor functions as a result of limbs spasticity, which leads to …

Objective: To compare the efficacy of botulinum toxin type A injection guided by different
localizing techniques, electrical stimulation and palpation, to treat spasticity of the ankle …

The objective of this study was to investigate the effects of botulinum toxin A (BTXA)
treatment on impairment and function of the upper limb during a 2-year follow-up period. A …

In this issue, Tedroff et al. report the outcome of a prospective uncontrolled study on the
effect of botulinum toxin A (BoNT-A) on the lower limb muscles of children with spastic …

The objective of this study was to measure the effect of lower extremity multilevel botulinum
toxin A injections and comprehensive rehabilitation on spasticity and to determine the …

Aim To assess the efficacy and safety of repeat abobotulinumtoxinA injections in reducing
upper limb spasticity in children with cerebral palsy (CP). Method This was a double‐blind …

Background Intramuscular injections of botulinum toxin A (BoNT-A) have been a
cornerstone in the treatment of spasticity for the last 20 years. In Norway, the treatment is …